Finance

Lists
ARTV:NASDAQ
Artiva Biotherapeutics Inc
$3.78
-1.31%
(-0.050) 1D
$3.82
+1.06% (+0.040)
After hours
Closed: Nov 20, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARTV...
Open
$3.82
High
$3.93
Low
$3.77
Mkt. cap
186.85M
Avg. vol.
1.15M
Volume
1.78M
52-wk high
$14.53
52-wk low
$2.96
EPS
-$3.00
Shares outstanding
49.43M
No. of employees
134
Open
$3.82
High
$3.93
Low
$3.77
Mkt. cap
186.85M
Avg. vol.
1.15M
Volume
1.78M
52-wk high
$14.53
52-wk low
$2.96
EPS
-$3.00
Shares outstanding
49.43M
No. of employees
134
News stories
From web sources and news partners
About Artiva Biotherapeutics Inc
CEO-
Employees134
Founded2019
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 5 analysts giving stock ratings to ARTV in the past 3 months
Hold
Buy
1
Hold
4
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ARTV in the last 3 months.
Highest
Current $3.78
$35.00 (+825.93%)
Average
$14.33 (+279.10%)
Lowest
$4.00 (+5.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Roger Song
Jefferies
Hold
Downgraded
$4.00
+5.8%
10/28/2026
Gil Blum
Needham
Hold
Downgraded
-
-
10/27/2026
Martin Fan
Wedbush
Hold
Downgraded
$4.00
+5.8%
10/27/2026
David Nierengarten
Wedbush
Hold
Downgraded
$4.00
+5.8%
10/27/2026
Tyler Van Buren
TD Cowen
Hold
Downgraded
-
-
10/27/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$35.00
+825.9%
10/01/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$40.00
+958.2%
05/25/2026
Unknown Analyst
Jefferies
Buy
Maintained
$23.00
+508.5%
05/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
16.99M
19.31M
21.92M
25.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.94M
5.12M
4.96M
5.96M
Operating expense
21.93M
24.43M
26.89M
31.95M
Total operating expenses
21.93M
24.43M
26.89M
31.95M
Operating income
-21.93M
-24.43M
-26.89M
-31.95M
Other non operating income
-1.88M
2.00K
-1.00K
-9.00K
EBT including unusual items
-20.77M
-23.52M
-25.00M
-28.82M
EBT excluding unusual items
-22.65M
-23.52M
-25.00M
-28.82M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.77M
-23.52M
-25.00M
-28.82M
Net profit margin
-
-
-
-
Earnings per share
-0.84
-0.95
-0.63
-0.56
Interest and investment income
1.16M
912.00K
1.89M
3.14M
Interest expense
-
-
-
-
Net interest expenses
1.16M
912.00K
1.89M
3.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.27M
-23.76M
-26.20M
-31.20M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps